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Abstract: Obesity is a global health problem. It is also known to be a risk factor for the 
development of metabolic disorders, type 2 diabetes, systemic hypertension, cardiovascular 
disease, dyslipidemia, and atherosclerosis. In this study, we screened crude extracts from 
400 plants to test their anti-obesity activity using porcine pancreatic lipase assay (PPL; 
triacylglycerol lipase, EC 3.1.1.3) in vitro activity. Among the 400 plants species examined, 
44 extracts from plants, showed high anti-lipase activity using 2,4-dinitrophenylbutyrate as 
a substrate in porcine pancreatic lipase assay. Furthermore, 44 plant extracts were 
investigated for their inhibition of lipid accumulation in 3T3-L1 cells. Among these   
44 extracts examined, crude extracts from 4 natural plant species were active.   
Salicis Radicis Cortex had the highest fat inhibitory activity, whereas Rubi Fructus,  
Corni Fructus, and Geranium nepalense exhibited fat inhibitory capacity higher than 30% 
at 100 μg/mL in 3T3-L1 adipocytes, suggesting anti-obesity activity. These results suggest 
that four potent plant extracts might be of therapeutic interest with respect to the treatment 
of obesity. 
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1. Introduction 
Obesity is a chronic metabolic disorder caused by an imbalance between energy intake and 
expenditure. Overweight and obesity are defined as abnormal or excessive fat accumulation that 
presents a risk to health [1–4]. Many scientific communities have become increasingly interested in the 
molecular regulation of triglyceride synthesis and in pharmaceutical approaches to reduce fat 
absorption and storage due to phytochemicals, presenting an exciting opportunity for the discovery of 
newer anti-obesity agents [5–7]. The regulation of fatty acid and triglyceride availability in biological 
responses depends on the activity of lipolytic enzymes present in fatty acid metabolism in adipose 
tissue [8–10]. 
The characterization and identification of several genes involved in lipid metabolism have yielded a 
rich pool of potential targets for drugs to treat obesity and other metabolic syndromes [11–14]. 
Pancreatic lipase, the main lipid digesting enzyme, removes fatty acids from the α and α′ positions of 
dietary triglycerides, which yield the lipolytic product β-monoglyceride and long chain saturated and 
polyunsaturated fatty acids. Inhibition of pancreatic lipase is an attractive targeted approach for the 
discovery of potent anti-obesity agents for obesity treatment [15,16]. 
One of the screening strategies used in the discovery of anti-obesity drugs is to search for potent 
lipase inhibitors from plant extracts. Plants have been used as traditional natural medicines for healing 
many diseases. In particular, various oriental medicinal plants are reported to have biological   
activity [17]. In this study, we screened crude extracts from natural sources as potential anti-obesity 
agents by monitoring their anti-lipase activity. We also elucidated anti-obesity effects on lipid 
accumulation in cultured 3T3-L1 adipocytes by measuring Oil Red O staining and triglyceride (TG) 
contents as indicators of lipid accumulation. Among the plant extracts screened, the four most 
promising extracts (Rubi Fructus, Corni Fructus, Salicis Radicis Cortex, and Geranium nepalense) 
might be of therapeutic interest with respect to the treatment of obesity. To the best of our knowledge, 
these plant extracts have not been previously screened for their lipid inhibitory activity. 
2. Experimental Methods 
2.1. Chemicals 
Four-hundred kinds of plants were purchased from a plant extract bank at Korea Research Institute 
of Bioscience & Biotechnology (KRIBB), and were authenticated by H.K. Lee. A collection of 
voucher specimens is available for confirmation in the Plant Extract Bank, Korea Research Institute of 
Bioscience and Biotechnology, Daejeon, Republic of Korea. The plant extracts were dissolved in 
dimethylsulfoxide (DMSO) and used as samples for screening tests. Orlistat, p-nitrophenyl butyrate 
(NPB), and lipase (Type II: from Porcine pancreas) were purchased from Sigma-Aldrich Chemical Co. 
(St. Louis, MO, USA). All reagents were of the highest grade available. 
2.2. Preparation of Natural Extracts 
The plants were extracted three times with ethanol, and extracts were obtained through the removal 
of the solvent during evaporation. The concentrated samples were stored at −20 °C for further study. Int. J. Mol. Sci. 2012, 13                 
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Extracts were dissolved in DMSO at a final concentration that did not affect enzyme activity within the 
total volume (1%). 
2.3. Pancreatic Lipase Inhibition Assay 
Porcine pancreatic lipase (PPL, type II) activity was measured using p-nitrophenyl butyrate   
(p-NPB) as a substrate. The method used for measuring the pancreatic lipase activity was modified 
from that previously described by Kim, et al. and Zheng, et al. [18,19]. PPL stock solutions (1 mg/mL) 
were prepared in a 0.1 mM potassium phosphate buffer (pH 6.0) and the solutions were stored at −20 °C. 
To determine the lipase inhibitory activity, the extracts (final concentrations 100, 50, 25, 10, 5, 2.5, 
1.25 μg/mL) or Orlistat (at same concentrations) as a positive control were pre-incubated with PPL for 
1 h in a potassium phosphate buffer (0.1 mM, pH 7.2, 0.1% Tween 80) at 30 °C before assaying the 
PPL activity. The reaction was then started by adding 0.1 μL NPB as a substrate, all in a final volume 
of 100 μL. After incubation at 30 °C for 5 min, the amount of p-nitrophenol released in the reaction 
was measured at 405 nm using a UV-Visible spectrophotometer (BioTek Synergy HT, Winooski, VT, USA). 
The activity of the negative control was also examined with and without an inhibitor. The inhibitory 
activity (I) was calculated according to the following formula: 
Inhibitory activity (I%) = 100 − ((B − b)/(A − a) × 100) 
where A is the activity without inhibitor; a is the negative control without inhibitor; B is the activity 
with inhibitor; and b is the negative control with inhibitor. DMSO was used as negative control and its 
activity was also examined. 
2.4. Cell Culture and Differentiation 
3T3-L1 preadipocytes were obtained from ATCC (Manassas, VA, USA). 3T3-L1 preadipocytes 
were grown in DMEM supplemented with 10% (v/v) heat-inactivated FBS at 37 °C in an atmosphere 
containing 5% CO2. To induce adipocyte differentiation, 2-day post-confluent 3T3-L1 preadipocytes 
(day 0) were stimulated for 48 h (day 2) with an inducer (10 μg/mL insulin, 2.5 μM dexamethasone, 
and 0.5 mM 3-isobutyl-1-methylxanthine) including natural extracts, and then maintained for 6 days 
(day 8) in DMEM supplemented with 10% FBS and 10 μg/mL insulin including natural extracts.  
3T3-L1 cells were treated with natural extracts in DMEM supplemented with 10% FBS for 2 days  
(day 10). To examine the effect of natural extracts on adipocyte differentiation in 3T3-L1 cells, the 
media and natural extracts were changed every 2 days until the end of the experiment at day 10. 
2.5. Cell Viability and Oil Red O Staining Intracellular Triglycerides 
Cell viability was determined colorimetrically using an MTT assay [20]. Cells cultured in DMEM 
medium were treated with natural extracts at a final concentration of 100 μg/mL for 2 days, and then 
incubated with a 5 mg/mL MTT (3-(4,5-dimetyl-2-thiazolyl)-2,5-diphenyltetrazoliumbromide) solution 
(Sigma) for 3 h. After the cells were dissolved in 0.04 N HCl (in isopropanol), the formazane level was 
analyzed by measuring the optical density (OD) at 570 nm (against OD at 630 nm) [18]. 3T3-L1 
adipocytes were washed with PBS and fixed with 10% formalin for 30 min. After two washes with 
distilled water, the cells were stained for at least 1 h at room temperature in a freshly diluted Oil Red O Int. J. Mol. Sci. 2012, 13                 
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solution (Oil Red O stock solution used is 0.5% Oil Red O in isopropanol). Finally, the dye retained in 
the 3T3-L1 cells was eluted with isopropanol and quantified by measuring the absorbance at 500 nm. 
2.6. Measurement of Triglyceride (TG) and Glycerol 
Cellular TG contents were measured using a commercial TG assay kit (Asan Pharm. Co., Seoul, 
Republic of Korea) according to the manufacturer’s instructions. Cells were treated with plant extracts 
at concentrations of 100 μg/mL in 6-well plates during adipocyte differentiation for 6 days. The cells 
were washed twice with phosphate-buffered saline (PBS), scraped in 75 μL of a homogenizing 
solution (154 mM KCl, 1 mM EDTA and 50 mM Tris, pH 7.4), and sonicated to homogenize cell 
suspension. The residual cell lysate was centrifuged at 3000× g for 5 min at 25 °C to remove fat layers. 
The supernatants were assayed for TG and protein contents. TG was normalized to the protein 
concentration determined by the Bradford assay using bovine serum albumin (BSA) as standard. The 
results were expressed in milligrams of TG per milligram of cellular protein. Lipolysis was assessed 
through the measurement of glycerol released (Free glycerol reagent, Sigma, St. Louis, MO, USA) into 
the medium, according to the manufacturer’s instructions [21]. Briefly, differentiated 3T3-L1 
adipocytes were treated with plant extracts for 24 h. After incubation, 50 μL of the medium was 
incubated with 200 μL of a Free Glycerol Reagent for 15 min at room temperature. The glycerol was 
quantified by measuring absorbance at 540 nm. 
2.7. Statistics 
Statistical analysis was done by using one way analysis of variance using the SPSS program [22]. 
Values of p < 0.05 were considered to be statistically significant. 
3. Results and Discussion 
3.1. Anti-Lipase Activity of Crude Natural Source Extracts 
Four-hundred crude extracts were prepared from natural plant species found in Korea or Asia and 
their anti-lipase activity was investigated at a concentration of 100 μg/mL for PPL inhibition. The 
inhibitory activities towards pancreatic lipase are reported in Table 1. Among the 400 plant extracts 
examined, 44 crude extracts from natural plant species, at a concentration of 100 μg/mL, significantly 
inhibited PPL in vitro activity when using a 2,4-dinitrophenylbutirate-based assay. Among those 
examined, four of the extracts showed a relatively high anti-lipase activity of more than 30%. The 
significant inhibition of PPL was observed up to 32.5% with Rubi Fructus fruit, 34.8% with   
Corni Fructus fruit, 38% with Salicis Radicis Cortex bark and 31.4% with Geranium nepalense whole 
grass, respectively. Treatment with Orlistat (at final concentration 100 μg/mL) as a positive control, a  
well-known anti-lipase agent, significantly inhibited the PPL activity up to 42%. Orlistat, a 
hydrogenated derivative of lipstatin, is the only pancreatic lipase inhibitor currently approved for a 
long-term treatment of obesity. Crude extracts of Rubi Fructus, Corni Fructus, Salicis Radicis Cortex, 
and  Geranium nepalense were further investigated for their PPL inhibitory effects at different 
concentrations, and a dose-response curve was obtained, as shown in Figure 1. Int. J. Mol. Sci. 2012, 13                 
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Table 1. Forty four plant extracts that inhibit porcine pancreatic lipase (PPL). 
No.  Latin Name  Scientific Name  Family Name 
Plant 
Part 
Inhibition 
(%) * 
1  Platycodi Radix  Platycodon grandiflorum A. De Candolle  Campanulaceae  Root  3.5 ± 0.7
2  Aconiti Tuber  Aconitum carmichaeli Debeaux  Ranunculaceae  Root  12.1 ± 1.1
3  Cannabis Semen  Cannabis sativa Linne  Moraceae  Seed  7.7 ± 0.2
4  Chaenomelis Fructus  Chaenomeles sinensis (Thouin) Koehne  Rosaceae  Fruit  7.1 ± 0.7
5  Actinidiae Fructus  Actinidia chinensis  Actinidiaceae  Fruit  3.2 ± 0.2
6  Tribuli Semen  Tribulus terrestris  Zygophyllaceae  Seed  2.5 ± 0.6
7  Lilie Bulbus  Lilium brownii var. viridulun Baker  Liliaceae  Stem  6.5 ± 1.2
8  Luffae Fructus Retinervus Luffa cylindrica Roemer  Cucurbitaceae  Fruit  8.2 ± 1.4
9  Crataegi Fructus  Crataegus pinnatifida Bunge var. typica Schneider Rosaceae  Fruit  5.5 ± 1.2
10  Puerariae Radix  Pueraria thunbergiana Bentham  Leguminosae  Root  3.2 ± 0.1
11  Nardostachyos Rhizoma  Nardostachys chinensis Batal  Valerianaceae  Rhizoma  6.4 ± 0.5
12  Zizyphi Fructus  Zizyphus jujuba Miller var. inermis Rehder  Rhamnaceae  Fruit  6.6 ± 1.5
13  Akebiae Caulis  Akebia quinata Decaisne  Lardizabalaceae  Stem  11.5 ± 0.1
14  Quisqalis Fructus  Quisqualis indica Linné  Combretaceae  Fruit  11.8 ± 0.3
15  Loranthi Ramulus  Loranthus parasticus Merr.  Loranthaceae 
Whole 
grass 
13.5 ± 0.7
16  Schizandrae Fructus  Schizandra chinensis Baillon  Schizandraceae  Fruit  5.8 ± 0.2
17  Lonicerae Folium  Lonicera japonica Thunberg  Caprifoliaceae  Stem  6.4 ± 0.5
18  Rehmaniae Radix Preparata Rehmannia glutinosa  Scrophulariaceae  Root  6.8 ± 1.1
19  Dipsaci Radix  Dipsacus asperoides C. Y. Cheng et T. M. Ai  Dipsacaceae  Root  12.5 ± 0.3
20  Morindae Radix  Morinda officinalis How  Rubiaceae  Root  3.9 ± 0.7
21  Perillae Semen  Perilla sikokiana Nakai  Labiatae  Seed  8.4 ± 0.3
22  Pruni Nakaii Semen  Prunus nakaii Leveille  Rosaceae  Seed  7.7 ± 0.6
23  Meliae Fructus  Melia azedarach Linné var. japonica Makino  Meliaceae  Fruit  8.6 ± 0.8
24  Bletillae Rhizoma  Bletilla striata (Thunberg) Reichenbach fil.  Orchidaceae  Rhizoma  12.1 ± 0.4
25  Hedyotidis Diffusae Herba Oldenlandia diffusa (Willd.) Roxburgh  Rubiaceae 
Whole 
grass 
1.80 ± 0.4
26  Hoelen rubra  Poria cocos wolf  Polyporaceae  Bark  12.7 ± 0.5
27  Gastrodiae Rhizoma  Gastrodia Blume  Orochidaceae  Rhizoma  8.4 ± 0.8
28  Gentianae Scabrae Radix  Gentiana scabra  Sympetalae  Root  7.5 ± 1.1
29  Cuscutae Semen crudus  Cuscuta chinensis Lamark  Convolvulaceae  Seed  5.8 ± 0.4
30  Tetrapanacis Medulla  Tetrapanax papyriferus K. Koch  Araliaceae  Stem  6.6 ± 0.7
31  Fritillariae Bulbus  Fritillaria thunbergii Miquel  Liliaceae  Stem  8.7 ± 0.5
32  Patriniae Radix  Patrinia villosa Jussieu  Valerianaceae  Root  7.7 ± 1.4
33  Scutellariae Radix  Scutellaria baicalenis Georgi  Labiatae  Root  8.7 ± 0.4
34  Astragali Radix  Astragalus membranaceus Bunge  Leguminosae  Root  7.4 ± 1.4
35  Phellodendri Cortex  Phellodendron amurense Ruprecht  Rutaceae  Bark  11.5 ± 0.2
36  Drynariae Rhizoma  Drynaria fortunei Smith.  Polypodiaceae  Rhizoma  10.5 ± 0.4
37  Rubi Fructus  Rubus coreanus Miquel  Rosaceae  Fruit  32.5 ± 1.1
38  Eriobotriae Folium  Eriobotrya japonica Lindley  Rosaceae  Leaf  9.8 ± 0.3
39  Corni Fructus  Cornus officinalis Siebold et Zuccarini  Cornaceae  Fruit  34.8 ± 2.3
40  Forsythiae Fructus  Forsythia koreana Nakai  Oleaceae  Fruit  5.7 ± 1.2
41  Salicis Radicis Cortex  Ulmus darvidian for. Suberose  Ulmaceae  Bark  38.0 ± 1.9Int. J. Mol. Sci. 2012, 13                 
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Table 1. Cont. 
No.  Latin Name  Scientific Name  Family Name  Plant Part 
Inhibition 
(%) * 
42  Ammomi Tsao-ko Frucuts  Amomum tsao-ko Crevost et Lemaire  Zingiberaceae  Fruit  7.5 ± 0.6
43  Polygoni Avicularis Herba Polygonum  aviculare  Linné  Polygonaceae  Whole grass  21.2 ± 1.7
44  Geranium Nepalense  Geranium thunbergii Siebold et Zuccarini Geraniaceae Whole  grass  31.4 ± 0.7
45 Orlistat       42.0 ± 2.5
* The inhibition of lipase activity by crude natural extracts was compared to the one observed with the 
positive control (Orlistat). Data are presented as average ± standard deviation (n = 3) and the anti-lipase 
activity was investigated at a concentration of 100 μg/mL for PPL inhibition. 
Figure 1. Porcine pancreatic lipase (PPL) inhibitory activities of Rubi Fructus,  
Corni Fructus, Salicis Radicis Cortex, Geranium nepalense. Orlistat was used as a positive 
control. Experiments have been performed in triplicate. 
 
3.2. Effect of Cell Viability and Lipid Inhibition in 3T3-L1 Cells 
The 3T3-L1 adipocytes were cultured and differentiated in a Dulbecco Modified Eagle Medium 
containing 10% fetal bovine serum for 6 to 8 days in the absence and presence of 44 plant extracts (at a 
final concentration, 100 μg/mL) according to differentiating protocols. Extracts were dissolved in 
DMSO at a final concentration that did not affect cell activity within the total volume (1%). As shown 
in Figure 2, the 44 plant extracts at 100 μg/mL attenuated lipid accumulation in differentiated adipocytes 
as evidenced by Oil Red O staining. Among the natural extracts examined, the four potent natural 
extracts (Rubi Fructus, Corni Fructus, Salicis Radicis Cortex, and Geranium nepalense) were found to 
significantly reduce lipid accumulation in 3T3-L1 adipocytes, suggesting anti-obesity activity.   
In Figure 2A,B, the effects of plant extracts on fat droplet formation in 3T3-L1 cells, and inhibition 
through the quantification method of Oil Red O staining, were presented. To examine the effect of 
plant extracts on cell viability of 3T3-L1 preadipocytes, we performed an MTT assay, which assesses 
cell viability by measuring mitochondrial activity in 3T3-L1 cells treated with concentrations of crude Int. J. Mol. Sci. 2012, 13                 
 
 
1716
extracts. The potent crude extracts (Rubi Fructus,  Corni Fructus,  Salicis Radicis Cortex, and 
Geranium nepalense) screened have relatively low cytotoxicity to 3T3-L1 preadipocyte cells. The cell 
cytotoxicity remained approximately 90–100% (data not shown). 
Figure 2. Effects of plant extracts on Oil Red O staining in cultured 3T3-L1 adipocytes. 
(A) Effects of plant extracts on fat droplet formation in 3T3-L1 cells. It was stained with 
Oil Red O dye and examined using a light microscope; (B) Relative lipid content by 
quantification method of Oil Red O staining. Data are presented as average ± SD (n = 3).  
* indicates p < 0.05. 
 
As shown in Figure 3A, lipid accumulation was measured based on the TG contents of 3T3-L1 cells 
differentiated in the presence of natural extracts. Furthermore, the lipolysis was assessed through the 
measurement of glycerol released in culture medium for 24 h incubation, as shown in Figure 3B. The 
four natural extracts that exhibited inhibitory activity towards pancreatic lipase (Rubi Fructus,  
Corni Fructus, Salicis Radicis Cortex, and Geranium nepalense) were found to inhibit triglyceride 
accumulation in 3T3-L1 adipocytes and trigger lipid metabolism process to glycerol release. 
Rubi Fructus, the unripe fruit of Rubus Chingii Hu belonging to the Rosaceae family, can be found 
in many parts of the Asia, especially in China. In general, Rubi Fructus has estrogenic effect, promote 
lymphocyte proliferation and elevate testosterone level by promoting the activity of steroid 
synthesizing enzymes and by inhibiting their degradation [23]. Corni Fructus, the pulp of   
Cornus officinalis sieb. belonging to the Cornaceae in family, can be found in China, Japan and Korea. 
The biological activity of Corni Fructus was reported to relieve cyclophosphamid-induced leukopenia Int. J. Mol. Sci. 2012, 13                 
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and to have antibacterial effects [24]. Salicis Radicis Cortex belonging to the Ulmaceae in family was 
reported to have antioxidant, antitumor, antimetastatic effects [25], to increase NO synthase activity [26], 
to lower LDL cholesterol levels [27], to prevent cancer development and metastasis [28] and to be 
effective in wound healing, angiogenesis, and cardiovascular disease [29]. Geranium Nepalense 
belonging to the Geraniaceae in family was reported to have antibacterial and antifungal effects [30]. 
Even though these four plants have reported to have various biological activities, there was no report 
indicating them to have lipid inhibitory activity. 
Figure 3. Effects of plant extracts on adipocyte differentiation in 3T3-L1 cells.   
(A) Triglyceride (TG) accumulation was measured by TG contents of 3T3-L1 cells 
differentiated in the presence of natural extracts; (B) Lipolysis was assessed by the 
measurement of glycerol released into the medium. Data are presented as average ± SD (n = 3). 
* indicates p < 0.05. 
 
4. Conclusions 
Obesity is a risk factor for metabolic syndromes, and a flexible approach for the treatment of 
obesity is to promote early adipogenesis in adipose tissue, thereby leading to the replacement of 
enlarged adipocytes that secrete inflammatory factors with small adipocytes. In this study, we screened 
crude anti-obesity drugs from four-hundred plant extracts on in vitro enzymatic lipase activity. Among 
400 plant extracts examined, 44 extracts from plant extracts significantly inhibited against in vitro  
anti-lipase activity. Among 44 natural extracts examined, the four plant extracts were active to inhibit 
lipid formation in 3T3-L1 adipocytes, suggesting their use as crude anti-obesity agents. Among them, 
Salicis Radicis Cortex had highest fat inhibition activity. Therefore, these results suggest that these 
four active plant extracts could be useful for prevention or treatment of obesity. Int. J. Mol. Sci. 2012, 13                 
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